Speranskoside is a dual COX-2 / 15-LOX inhibitor with a COX-2 IC 50 of 2.62 μg/mL and a 15-LOX IC 50 of 5.51 μg/mL. Speranskoside can be used for the research of gastric ulcers.
Products | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Gastric Disease | Products > Disease Areas > Peptic Ulcer Disease | Products > Disease Areas > Gastric Ulcer | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > COX | Products > Signaling Pathways > Lipoxygenase
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。